Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Triheptanoin

EU orphan designation number: EU/3/15/1495   
Active ingredient: Triheptanoin
Indication: Treatment of glucose transporter type-1 deficiency syndrome
Sponsor: Ultragenyx UK Limited
c/o Regus, Level 33, 25 Canada Square, Canary Wharf, London E14 5LB, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
25/05/2015 Orphan designation EMA/OD/007/15 (2015)3575 of 21/05/2015
12/08/2015 Transfer of orphan designation EMA/OD/007/15/T/01 (2015)5788 of 10/08/2015